Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
Q Cheng, J Sun, H Zhong, Z Wang, C Liu… - Frontiers in …, 2024 - frontiersin.org
Background Cardiovascular disease (CVD) poses a significant global health and economic
challenge, with atherosclerosis being a primary cause. Over the past 40 years, substantial …
challenge, with atherosclerosis being a primary cause. Over the past 40 years, substantial …
[HTML][HTML] Mac-1 deficiency ameliorates pressure overloaded heart failure through inhibiting macrophage polarization and activation
QY Lin, WJ Yu, J Bai, WX Jiang, HH Li - Biochimica et Biophysica Acta (BBA …, 2024 - Elsevier
Persistent pressure overload commonly leads to pathological cardiac hypertrophy and
remodeling, ultimately leading to heart failure (HF). Cardiac remodeling is associated with …
remodeling, ultimately leading to heart failure (HF). Cardiac remodeling is associated with …
Does Helping Others Always Benefit Health? Longitudinal Evidence on the Relationship between Helping Behavior and Depression: The Mediating Role of Life …
Y Cheng, Y Wei, SL Tang - Depression and Anxiety, 2024 - Wiley Online Library
Background. This study aims to explore whether helping behavior is always beneficial for
alleviating depression or if there is a “moderation is the key” effect. Materials and Methods …
alleviating depression or if there is a “moderation is the key” effect. Materials and Methods …
[HTML][HTML] Circulating palmitoyl sphingomyelin levels predict the 10-year increased risk of cardiovascular disease death in Chinese adults: findings from the Da Qing …
X Qian, H Jia, J Wang, S He, M Yu, X Feng… - Cardiovascular …, 2024 - Springer
Background Higher levels of palmitoyl sphingomyelin (PSM, synonymous with
sphingomyelin 16: 0) are associated with an increased risk of cardiovascular disease (CVD) …
sphingomyelin 16: 0) are associated with an increased risk of cardiovascular disease (CVD) …
Mediation effect of antithrombin III between chronic renal insufficiency and chronic coronary artery disease in T2DM patients
R Sun, J Jia, S Wang, Z Wang, C Wang, Y Xu, Y Yuan - Endocrine, 2024 - Springer
Purpose The study aimed to investigate the potential effect of Antithrombin III (ATIII) between
chronic renal insufficiency and chronic coronary artery disease (chronic CAD) in type 2 …
chronic renal insufficiency and chronic coronary artery disease (chronic CAD) in type 2 …